Tracon Pharmaceuticals, Inc. 3 SEC Filings

Filed On	Filing
13 May 2024	Form 3: Lazar David E., Chief Business Dev Officer No securities owned
09 Feb 2023	Form 3: Adams Bonne J., Chief Operating Officer Holds 4,267 shares of Common Stock
13 Oct 2021	Form 3: Lam Carol C., Director No securities owned
08 Mar 2021	Form 3: Johnson-Pratt Lisa, Director No securities owned
17 Sep 2020	Form 3: Chart Westcott Living Trust, 10% owner and 3 others Holds 1,840,078 shares of Common Stock, par value $0.001 per share
14 Sep 2020	Form 3: Ikarian Capital, Llc, 10% owner Holds 1,840,078 shares of Common Stock, par value $0.001 per share
31 Aug 2020	Form 3: Opaleye Management Inc., 10% owner Holds 1,170,788 shares of Common Stock, $0.001 par value
18 Mar 2020	Form 3: Pelletier Saundra L, Director No securities owned
30 Sep 2019	Form 3: Brown Scott B., Chief Accounting Officer (PAO) Holds 10,962 shares of Common Stock
30 May 2018	Form 3: Wiggins Mark C, Chief Business Officer No securities owned
05 Apr 2018	Form 3: Puissance Cross-Border Opportunities V Llc, 10% owner and 5 others Holds 4,601,768 shares of Common Stock
06 Oct 2015	Form 3: Shazer Ronald L, Chief Medical Officer No securities owned
27 Feb 2015	Form 3: Worland Stephen T, Director No securities owned
29 Jan 2015	Form 3: Barrett M James, 10% owner
29 Jan 2015	Form 3: Barris Peter J, 10% owner
29 Jan 2015	Form 3: Baskett Forest, 10% owner
29 Jan 2015	Form 3: Drant Ryan D, 10% owner
29 Jan 2015	Form 3: Florence Anthony A. Jr., 10% owner
29 Jan 2015	Form 3: Kerins Patrick J, 10% owner
29 Jan 2015	Form 3: Kolluri Krishna Kittu, 10% owner

Comments